Recombinant human follicle-stimulating hormone produces more oocytes with a lower total dose per cycle in assisted reproductive technologies compared with highly purified human menopausal gonadotrophin: a meta-analysis
2010
Background
Human menopausal gonadotrophins and recombinant human follicle stimulating hormone are the two main gonadotrophin products utilized for controlled ovarian stimulation in assisted reproductive technologies. In this meta-analysis, the number of oocytes was designated as the most relevant endpoint directly resulting from ovarian stimulation, and therefore where the drug effect may be estimated with the best sensitivity.
Keywords:
- Menotropins
- Infertility
- Andrology
- Ovulation induction
- Endocrinology
- Pregnancy rate
- Internal medicine
- Human menopausal gonadotrophin
- Stimulation
- Menstrual cycle
- Biology
- Follicle-stimulating hormone
- Randomized controlled trial
- Absolute risk reduction
- Strictly standardized mean difference
- Relative risk
- reproductive technology
- Pregnancy
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
43
References
47
Citations
NaN
KQI